Commercial Insurance Rates and Coding for Lymphedema Procedures: The Current State of Confusion and Need for Consensus.

Danielle H Rochlin, Clifford C Sheckter, Philip S Brazio, Michelle R Coriddi, Joseph H Dayan, Babak J Mehrara, Evan Matros
Author Information
  1. Danielle H Rochlin: From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.
  2. Clifford C Sheckter: Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University Medical Center.
  3. Philip S Brazio: Division of Plastic and Reconstructive Surgery, Department of Surgery, Cedars-Sinai Medical Center.
  4. Michelle R Coriddi: From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.
  5. Joseph H Dayan: From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.
  6. Babak J Mehrara: From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.
  7. Evan Matros: From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Abstract

BACKGROUND: Surgical treatment of lymphedema has outpaced coding paradigms. In the setting of ambiguity regarding coding for physiologic procedures [lymphovenous bypass (LVB) and vascularized lymph node transplant (VLNT)], we hypothesized that there would be variation in commercial reimbursement based on coding pattern.
METHODS: The authors performed a cross-sectional analysis of 2021 nationwide hospital pricing data for 21 CPT codes encompassing excisional (direct excision, liposuction), physiologic (LVB, VLNT), and ancillary (lymphangiography) procedures. Within-hospital ratios (WHRs) and across-hospital ratios (AHRs) for adjusted commercial rates per CPT code quantified price variation. Mixed effects linear regression modeled associations of commercial rate with public payer (Medicare and Medicaid), self-pay, and chargemaster rates.
RESULTS: A total of 270,254 commercial rates, including 95,774 rates for physiologic procedures, were extracted from 2863 hospitals. Lymphangiography codes varied most in commercial price (WHR, 1.76 to 3.89; AHR, 8.12 to 44.38). For physiologic codes, WHRs ranged from 1.01 (VLNT; free omental flap) to 3.03 (LVB; unlisted lymphatic procedure), and AHRs ranged from 5.23 (LVB; lymphatic channel incision) to 10.36 (LVB; unlisted lymphatic procedure). Median adjusted commercial rates for excisional procedures ($3635.84) were higher than for physiologic procedures ($2560.40; P < 0.001). Commercial rate positively correlated with Medicare rate for all physiologic codes combined, although regression coefficients varied by code.
CONCLUSIONS: Commercial payer-negotiated rates for physiologic procedures were highly variable both within and across hospitals, reflective of variation in CPT codes. Physiologic procedures may be undervalued relative to excisional procedures. Consistent coding nomenclature should be developed for physiologic and ancillary procedures.

References

  1. Ann Surg. 2022 Oct 1;276(4):635-653 [PMID: 35837897]
  2. Plast Reconstr Surg Glob Open. 2021 Jun 16;9(6):e3630 [PMID: 34150425]
  3. Radiology. 2022 Mar;302(3):622-624 [PMID: 34846206]
  4. J Gen Intern Med. 2022 Nov;37(14):3577-3584 [PMID: 34902095]
  5. JAMA Netw Open. 2021 Dec 1;4(12):e2140526 [PMID: 34932108]
  6. J Gen Intern Med. 2022 Oct;37(13):3495-3497 [PMID: 35029785]
  7. Plast Reconstr Surg. 2022 Apr 1;149(4):700e-710e [PMID: 35157612]
  8. Ann Surg Oncol. 2015 Jul;22(7):2424-30 [PMID: 25515196]
  9. Microsurgery. 2021 Jan;41(1):34-43 [PMID: 32845534]
  10. J Surg Oncol. 2022 Mar;125(4):603-614 [PMID: 34989418]
  11. J Surg Oncol. 2017 Jan;115(1):68-71 [PMID: 27449974]
  12. Breast Cancer Res Treat. 2016 Feb;156(1):73-9 [PMID: 26895326]
  13. J Am Coll Surg. 2021 Jun;232(6):982-994 [PMID: 33766726]
  14. Plast Reconstr Surg. 2013 Jun;131(6):1286-1298 [PMID: 23714790]
  15. Microsurgery. 2022 Jul;42(5):433-440 [PMID: 34994481]
  16. Ann Plast Surg. 2015 May;74(5):573-9 [PMID: 25875724]
  17. Plast Reconstr Surg. 2014 Apr;133(4):905-913 [PMID: 24352208]
  18. Otolaryngol Head Neck Surg. 2022 Aug;167(2):262-265 [PMID: 34582305]
  19. JAMA. 2021 Jun 4;: [PMID: 34086052]
  20. J Surg Oncol. 2018 May;117(6):1148-1156 [PMID: 29355987]
  21. J Surg Oncol. 2020 Jun;121(8):1175-1178 [PMID: 32207151]
  22. J Surg Oncol. 2020 Jan;121(1):67-74 [PMID: 31209885]
  23. J Am Coll Surg. 2021 Jun;232(6):837-845 [PMID: 33684564]
  24. Ann Surg Oncol. 2017 Jun;24(6):1475-1481 [PMID: 27734176]
  25. Scand J Surg. 2003;92(4):287-95 [PMID: 14758919]
  26. Ann Surg. 2022 Oct 1;276(4):e255-e263 [PMID: 32889875]
  27. Plast Reconstr Surg. 2021 May 1;147(5):876e-877e [PMID: 33877076]
  28. Plast Reconstr Surg. 2023 Sep 1;152(3):476e-487e [PMID: 36847669]
  29. JAMA Intern Med. 2021 Oct 1;181(10):1396-1397 [PMID: 34125138]
  30. Plast Reconstr Surg. 2022 Jul 1;150(1):169-180 [PMID: 35583944]
  31. Int J Surg. 2021 Nov;95:106107 [PMID: 34517136]
  32. Plast Reconstr Surg. 2021 Apr 1;147(4):975-993 [PMID: 33761519]
  33. J Am Coll Radiol. 2008 Apr;5(4):555-60 [PMID: 18359442]
  34. Ann Surg. 2021 Dec 1;274(6):e581-e588 [PMID: 31850991]

Grants

  1. KL2 TR003143/NCATS NIH HHS
  2. P30 CA008748/NCI NIH HHS
  3. R01 CA278599/NCI NIH HHS
  4. R01 HL111130/NHLBI NIH HHS

MeSH Term

Aged
Humans
United States
Medicare
Consensus
Cross-Sectional Studies
Lymphedema
Lymphatic Vessels

Word Cloud

Created with Highcharts 10.0.0proceduresphysiologiccommercialratesLVBcodescodingVLNTvariationCPTexcisionalratelymphaticCommercialancillaryratiosWHRsAHRsadjustedcodepriceregressionMedicarehospitalsvaried13rangedunlistedprocedureBACKGROUND:Surgicaltreatmentlymphedemaoutpacedparadigmssettingambiguityregarding[lymphovenousbypassvascularizedlymphnodetransplant]hypothesizedreimbursementbasedpatternMETHODS:authorsperformedcross-sectionalanalysis2021nationwidehospitalpricingdata21encompassingdirectexcisionliposuctionlymphangiographyWithin-hospitalacross-hospitalperquantifiedMixedeffectslinearmodeledassociationspublicpayerMedicaidself-paychargemasterRESULTS:total270254including95774extracted2863LymphangiographyWHR7689AHR812443801freeomentalflap03523channelincision1036Median$363584higher$256040P<0001positivelycorrelatedcombinedalthoughcoefficientsCONCLUSIONS:payer-negotiatedhighlyvariablewithinacrossreflectivePhysiologicmayundervaluedrelativeConsistentnomenclaturedevelopedInsuranceRatesCodingLymphedemaProcedures:CurrentStateConfusionNeedConsensus

Similar Articles

Cited By